About US
Contact us
-
Novartis expands radiotherapy manufacturing network with $85M plant in ChinaWhen it comes to expanding radiotherapy manufacturing capacity for Lutathera and Pluvicto, Novartis is putting its money where its mouth is. The Swiss pharma is building a new radiotherapy production2023/11/14
-
J&J books manufacturing space at Fujifilm Diosynth's upcoming mega-plant in North CarolinaWith a year and change still left before Fujifilm Diosynth cuts the ribbon on a massive biomanufacturing facility in North Carolina, the CDMO has already lined up its first client. Johnson & John2023/11/10
-
With FDA approval, Eli Lilly's weight loss drug Zepbound arrives to challenge Novo NordiskIn the Big Pharma battle to treat obesity, Novo Nordisk sprinted to an early lead, but Eli Lilly is catching up quickly. Wednesday, the Indianapolis-based companyscored FDA approvalfor its GIP/GLP-12023/11/10
-
Strides African unit nabs WHO first with nod to produce malaria treatmentUniversal Corporation Limited, a unit of Strides Pharma Science, became the first African drug manufacturer to snare a World Health Organization (WHO)pre-qualification(PDF) to produce the anti-malari2023/11/7
-
Pfizer cost-savings campaign reaches Ireland, where 100 production workers will lose jobsPfizer’s $3.5 billion cost-savings drive has made its way overseas. After job cuts hit several sites in the U.S., the pharma giantis reducing the headcount at one of its Irish manufacturing plants in2023/11/7
-
After scoring limited FDA nod, Sage and Biogen call an audible on pricing strategy for ZurzuvaeBefore Sage and Biogen’s Zurzuvae (zuranolone) won approval from the FDA for postpartum depression (PPD) in August, the companies had said that the highly anticipated first-in-class treatment would b2023/11/2
-
Sanofi stands behind 'accuracy of our accounts' amid reports of French manipulation probeSince launching the Regeneron-partneredantibody Dupixent in 2017, Sanofi has relied on the star medicine for sales growth.Now, though, an investigation in France calls into question some of the compa2023/11/2
-
WuXi XDC eyes $470.5M IPO to fuel manufacturing expansions at home and abroadWuXi's bioconjugation spinoffis set to break free onto the Hong Kong Stock Exchange this month, with plans to funnel hundreds of millions of dollars in proceeds back into its Asian manufacturing netw2023/10/31
-
With Amgen's biosim on the scene, J&J's Stelara looks poised to sidestep Medicare negotiations: HHSThere might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an2023/10/31
-
Merck raises revenue guidance thanks to a surprising bump from COVID-19 pill LagevrioIt’s been grounded in Europe and reduced to irrelevancy in the U.S., but Merck’s COVID-19 pill Lagevrio somehow remains a force. The antiviral treatmentracked upsales of $640 million in the third qua2023/10/27